This renewal application for the Oklahoma IDeA Network for Biomedical Research Excellence (OK-INBRE) proposes to further enhance the statewide research infrastructure and biomedical research capacity in Oklahoma by: i) building on our established OK-INBRE research network with a scientific focus to strengthen the lead and partner institutions' biomedical research expertise and infrastructure, ii) increasing the research capacity of Oklahoma by providing support to faculty, postdoctoral fellows and graduate students at OK-INBRE network partner institutions, iii) providing research opportunities for students from primarily undergraduate institutions (PUI), community colleges (CC), and minority serving institutions to serve as a pipeline for new students to enter into health research careers, and iv) enhancing the science and technology knowledge of Oklahoma's workforce. The OK-INBRE Network is comprised of two research intensive institutions, the University of Oklahoma Health Sciences Center (OUHSC) and the Oklahoma Medical Research Foundation (OMRF). These institutions are integrated and aligned with six PUIs and four CCs that are essential to the success of the OK-INBRE network. The statewide OK-INBRE network includes Langston University, the only Historically Black University in Oklahoma, and Northeastern State University, a PUI with the highest number of American Indians of any four year college in the nation. Additionally, Oklahoma's only accredited tribal college, along with four other PUIs and three additional CCs are included that educate large numbers of students from underrepresented groups. The scientific themes are multi-disciplinary and span the areas of Cancer, Developmental Biology, and Infectious Diseases. OK-INBRE will provide significant research resources to eight Research Project Investigators (RPIs), four from OUHSC/OMRF and four from the network PUIs. Specific career development and mentoring committees for each scientific theme will help the RPIs achieve scientific independence. In addition, smaller developmental grant awards for research and equipment will be provided to PUI faculty annually. Support for 35 undergraduate students also will be provided each year to provide a vibrant and dynamic summer undergraduate research program. OK-INBRE will support Bioinformatics and Proteomics Core facilities that will serve as statewide research and educational resources to provide faculty, trainees, and students throughout the state with access to the computational tools needed to enhance multidisciplinary biomedical research in Oklahoma. Uniquely, the Proteomics Core will not only play a central role in training the next generation of researchers in Oklahoma, but it will also be used as a resource for investigators in all IDeA-eligible states. Through workshops, seminars, research training, mentoring, and access to state-of-the-art core facilities, the OK-INBRE program will continue to enhance infrastructure and research capacity while increasing the overall science and technology knowledge of the Oklahoma workforce.

Public Health Relevance

The Oklahoma INBRE (OK-INBRE) program supports biomedical research in Cancer, Developmental Biology, and Infectious Diseases. OK-INBRE allows researchers in Oklahoma to be more competitive for federal research funding that leads to better medical diagnostics and novel therapies to treat human disease. OK-INBRE also enhances the pipeline of undergraduate and graduate students choosing careers in biomedical research to ensure there will be well-trained biomedical scientists in Oklahoma and throughout the country for future generations.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM103447-21
Application #
9919595
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Arora, Krishan
Project Start
2001-09-06
Project End
2024-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Rao, Chinthalapally V; Farooqui, Mudassir; Zhang, Yuting et al. (2018) Spontaneous development of Alzheimer's disease-associated brain pathology in a Shugoshin-1 mouse cohesinopathy model. Aging Cell :e12797
Borga, Chiara; Park, Gilseung; Foster, Clay et al. (2018) Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia :
Lahousse, Mieke; Park, Hae-Chul; Lee, Sang-Choon et al. (2018) Inhibition of anthrax lethal factor by ssDNA aptamers. Arch Biochem Biophys 646:16-23
Hardy, Rachel N; Simsek, Zinar D; Curry, Brandon et al. (2018) Aging affects isoproterenol-induced water drinking, astrocyte density, and central neuronal activation in female Brown Norway rats. Physiol Behav 192:90-97
Masilamani, Revathi; Cian, Melina B; Dalebroux, Zachary D (2018) Salmonella Tol-Pal Reduces Outer Membrane Glycerophospholipid Levels for Envelope Homeostasis and Survival during Bacteremia. Infect Immun 86:
Benbrook, Doris M; Janakiram, Naveena B; Chandra, Vishal et al. (2018) Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs 36:561-570
Seshadri, Sudarshan; Pope, Rosemary L; Zenewicz, Lauren A (2018) Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production. J Immunol 201:1267-1274
Budda, Scott A; Zenewicz, Lauren A (2018) IL-22 deficiency increases CD4 T cell responses to mucosal immunization. Vaccine 36:3694-3700
Yen, Ting-An; Dahal, Kaushalya Sharma; Lavine, Barry et al. (2018) Development and Validation of High Performance Liquid Chromatographic Method for Determination of Gentisic Acid and Related Renal Cell Carcinoma Biomarkers in Urine. Microchem J 137:85-89
Khandaker, Morshed; Riahinezhad, Shahram; Sultana, Fariha et al. (2018) Effect of Collagen-Polycaprolactone Nanofibers Matrix Coating on the In Vitro Cytocompatibility and In Vivo Bone Responses of Titanium. J Med Biol Eng 38:197-210

Showing the most recent 10 out of 93 publications